Venture Capital Investors
ALS Investment Fund
ALS Investment Fund is focused on making venture capital investments in technology startup companies.
Venture Investor Overview
Venture Investor
ALS Investment Fund
Investor Type
Venture Capital
Industry Focus
Biopharmaceutical
Contact Information
Mailing Address
182 Beacon St. 14
Boston, MA 02116
USA
Background Information
Overview
The ALS Investment Fund supports and finances biotech companies that develop drugs and diagnostics for the disease ALS (also called Lou Gehrig's disease). We invest globally, but our focus is on Europe and the US. ALS is a devastating disease; patients gradually loose their motoric functions until they are completely paralyzed. Average life expectancy after the first symptoms is 3--5 years. Our vision is that ALS patients will live longer and may even be cured in the long run. It's a matter of enough resources and the right talent to reach this goal.
Last Transaction
11/14/2023
Transaction History
Our records indicate that ALS Investment Fund invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.
11/14/2023
Series A
$140,840,000
3/9/2023
Series B
$88,000,000
12/21/2021
Series B
$98,000,000
12/10/2021
Series A
$12,000,000
1/8/2019
Series A
$40,000,000
7/17/2018
Series A
$32,000,000
6/20/2018
Series C
$36,000,000
Investor Contacts
Managing Partner
Felix Coerper
Funds
No fund closings have been recorded for this company.
Portfolio Companies
ALS Investment Fund has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.
San Francisco, CA 94103 USA
Browse more venture capital investors:
Alrai Capital | Alsace Business Angels
Share this article
About Our VC & M&A Database
This venture capital firm data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs